The UCI confirmed that it will appeal Alexandr Kolobnev’s case to the Court of Arbitration for Sport.
Kolobnev tested positive for hydrochlorothiazide, a banned diuretic, during the fourth stage of this summer’s Tour de France in what was the lone doping case of the 2011 edition.
UCI spokesman Enrico Carpani told VeloNews that the appeal was quietly filed with CAS within the past week.
“We didn’t agree with what the Russian federation ruled,” Carpani told VeloNews. “The deadline was Monday and we filed it with CAS. We will wait to see when there will be a hearing.”
In late October, the Russian cycling federation decided not to ban Kolobnev, 30, instead ruling only to slap him with a warning and a fine of 1,500 Swiss francs (about $1,700).
Russian commission chief Alexander Gusyatnikov told Reuters at the time that the federation, “found him guilty but also took into account extenuating circumstances.”
After reviewing the documents provided by the Russian federation, UCI lawyers decided to press forward to appeal the ruling, Carpani said.
“Their ruling didn’t conform with the UCI regulations,” Carpani said, adding that the UCI will press for a two-year ban for the Russian rider.
When reached by VeloNews at his home in Spain, Kolobnev said he did not realize the UCI had filed the appeal.
“I have not commented on my case and I will not until the process is completed,” Kolobnev said.
Kolobnev said he has been working with lawyers to prove that he “did not dope,” but refused to comment further on the case.
Kolobnev was dropped by his Katusha team in the wake of doping positive and he said he is without a contract for next season as he waits for the legal process to play out.
Hydrochlorothiazide is a product used for treating hypertension and triggers the body to remove excess liquid from the system. The diuretic is banned under WADA as it could be used as a possible masking agent.
In July, Kolobnev said, “I don’t know where it came from” and left the race during the Tour’s ninth stage.